Provided by Tiger Fintech (Singapore) Pte. Ltd.

Virpax Pharmaceuticals, Inc.

0.1665
-0.0115-6.46%
Post-market: 0.1643-0.0022-1.32%19:58 EDT
Volume:1.46M
Turnover:243.01K
Market Cap:4.42M
PE:-0.01
High:0.1764
Open:0.1710
Low:0.1608
Close:0.1780
Loading ...

BRIEF-Virpax Announces Positive Results For The Swine Model Dose Range Finding Study For Probudur™

Reuters
·
22 Nov 2024

Virpax Pharmaceuticals announces results from Probudur minipig DRF study

TIPRANKS
·
22 Nov 2024

Virpax Announces Positive Results for the Swine Model Dose Range Finding Study for Probudur™

THOMSON REUTERS
·
22 Nov 2024

Virpax Pharmaceuticals Inc - Minipigs Show Positive Tolerance to Probudur With No Adverse Effects

THOMSON REUTERS
·
22 Nov 2024

Virpax Pharma Gets Government Cooperation Deal Extension

Dow Jones
·
22 Nov 2024

Virpax Pharmaceuticals announces HHS pact over NES100 developmental extension

TIPRANKS
·
22 Nov 2024

BRIEF-Virpax Announces Agreement With U.S. Department Of Health And Human Services For Developmental Extension For NES100

Reuters
·
22 Nov 2024

Virpax Announces Agreement With the U.S. Department of Health and Human Services for the Developmental Extension for Nes100 Towards Ind for Acute and Chronic Non-Cancer Pain Alternative

THOMSON REUTERS
·
22 Nov 2024

Virpax Pharmaceuticals Announces New Chief Financial Officer

TIPRANKS
·
20 Nov 2024

BRIEF-Virpax Pharmaceuticals - Appointed Usama Chaudhry As CFO - SEC Filing

Reuters
·
20 Nov 2024

Virpax Pharmaceuticals - Appointed Usama Chaudhry as CFO

THOMSON REUTERS
·
20 Nov 2024

Spartan Capital Securities, LLC Serves as Sole Placement Agent in Virpax Pharmaceuticals, Inc.'s $5.0 Million Public Offering

GlobeNewswire
·
18 Nov 2024

Virpax Pharmaceuticals Announces $5M Public Offering

TIPRANKS
·
16 Nov 2024

BRIEF-Virpax Pharmaceuticals Announces Closing Of $5.0 Million Public Offering Of Common Stock And Pre-Funded Warrants

Reuters
·
16 Nov 2024

Virpax Pharmaceuticals, Inc. Announces Pricing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants

THOMSON REUTERS
·
13 Nov 2024

Virpax Pharmaceuticals, Inc. Announces Pricing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants

Business Wire
·
13 Nov 2024